AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 22, 2005). doi:10.1152/ajpheart.00395.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H2108    most recent
00395.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borge, B. A
Right arrow Articles by Reed, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borge, B. A
Right arrow Articles by Reed, R. K
Submitted on April 21, 2005
Accepted on December 15, 2005

Changes in plasma protein extravasation in rat skin during inflammatory challenges evaluated by microdialysis

Bengt A Borge1*, Vegard V Iversen1, and Rolf K Reed1

1 Department of Biomedicine, Section of Physiology, University of Bergen, 5009, Bergen, Norway

* To whom correspondence should be addressed. E-mail: bengt.borge{at}biomed.uib.no.

Docetaxel and prostaglandin E1 (PGE1) increase transcapillary protein extravasation and reduce interstitial fluid pressure in skin. In this study the microdialysate concentration (Cm) of 125I-Human serum albumin (125I-HSA) and different sized endogenous plasma proteins (EPP) was compared to evaluate changes in transcapillary extravasation of plasma proteins. 125I-HSA was also used to estimate changes in specific activity of albumin. Extravasation of 125I-HSA and EPP from plasma to interstitium in rat skin was compared during continuous administration of docetaxel and PGE1 by using microdialysis in anesthetized rats. Also, 20 ml of Ringer's solution (RS) was injected intravenously over 10 min in a separate group. Two hollow plasmapheresis fibers (3 cm, cut off 3000 kDa), one acting as control, were placed subcutaneously on back skin and perfused with RS (5 µl/min, 140 min, collected every 10 min). The size of the different EPP were estimated to be 73, 65, 56, 47 and 39 A, separated by a size-exclusion HPLC column and quantified by UV detection (280 nm). Docetaxel (0.5 mg/ml, n=5) increased Cm of 125I-HSA and EPP of size 73, 65, 56 and 39 A significantly (p<0.05) compared to control. PGE1 (20 µg/ml, n=6) increased Cm of 125I-HSA significantly (p<0.05), but none of the different sized EPP compared to control. Intravenous RS (20 ml, n=6) increased Cm of 125I-HSA and all the different sized EPP significantly (p<0.05) compared to control. Although the microdialysis method is able to monitor qualitative changes in capillary permeability, a quantitative determination of the capillary reflection coefficient or PS product was not possible, since steady-state between plasma and dialysate was not achieved during the measurement period. The different pattern of extravasation of EPP and 125I-HSA after docetaxel, PGE1, and RS indicates increased interstitial transport rate and/or increased capillary permeability after docetaxel and RS, while PGE1 increased transcapillary fluid flux without altering the permeability.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.